Phase II Study of 177 Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers ...

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials The following represents ...

Limitations of Radiographic Response Assessments of Systemic Therapy for Advanced Hepatocellular Carcinoma The following represents disclosure information provided by authors of this manuscript. All ...

POLARIS and Emerging Translational Efforts to Interrogate the Genomic Landscape of CDK4/6 Inhibitor Resistance The following represents disclosure information provided by authors of this manuscript.

To advance the call to action to optimize dosage of anticancer agents, FDA and ASCO cosponsored two multistakeholder workshops, Getting the Dose Right: Optimizing Dose Selection Strategies in Oncology ...

Clinical Significance of Extrachromosomal DNA in FGFR2 -Amplified Gastric Cancer: Therapeutic Implications From Clinical Experience ...